Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals

Molecules. 2020 Oct 14;25(20):4701. doi: 10.3390/molecules25204701.

Abstract

Cancer is a global health concern and one of the main causes of disease-related death. Even with considerable progress in investigations on cancer therapy, effective anti-cancer agents and regimens have thus far been insufficient. There has been compelling evidence that natural phytochemicals and their derivatives have potent anti-cancer activities. Plant-based anti-cancer agents, such as etoposide, irinotecan, paclitaxel, and vincristine, are currently being applied in medical treatments for patients with cancer. Further, the efficacy of plenty of phytochemicals has been evaluated to discover a promising candidate for cancer therapy. For developing more effective cancer therapy, it is required to apprehend the molecular mechanism deployed by natural compounds. MicroRNAs (miRNAs) have been realized to play a pivotal role in regulating cellular signaling pathways, affecting the efficacy of therapeutic agents in cancer. This review presents a feature of phytochemicals with anti-cancer activity, focusing mainly on the relationship between phytochemicals and miRNAs, with insights into the role of miRNAs as the mediators and the regulators of anti-cancer effects of phytochemicals.

Keywords: cancer; microRNA; natural compound; non-coding RNA; phytochemical.

Publication types

  • Review

MeSH terms

  • Animals
  • Anticarcinogenic Agents / pharmacology
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Clinical Trials as Topic
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Genes, Tumor Suppressor / drug effects
  • Humans
  • MicroRNAs / genetics*
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Phytochemicals / pharmacology*

Substances

  • Anticarcinogenic Agents
  • Antineoplastic Agents, Phytogenic
  • MicroRNAs
  • Phytochemicals